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Background: Ischemia/reperfusion (I/R) injury is harmful to the cardiovascular system and is responsible for the
inflammatory response and multiple organ dysfunctions. In this study we investigated the effect of activated
clotting time level on the aortic cross-clamping triggers a systemic inflammatory response and it effects to lungs
and heart.
Methods: End organ concentrations of interleukin-6 (IL-6), myeloperoxidase (MPO) and heat shock protein
70 (HSP-70) were determined in four groups of Spraque Dawley rats: ischemic control (operation with cross clamping
received IP of 0.9% saline at 2 ml/kg n=7) Sham (operation without cross clamping, n=7), heparin (ACT level about
200), High dose heparin (ACT level up to 600) The infrarenal aorta was clamped for 45 minutes by a mini cross
clamp approximately 1cm below the renal artery and 1cm iliac bifurcation in all groups without sham group.
Heparin was given intraperitoneal (IP) before the procedure. All rats were sacrificed 48 h later. In a second
experiment, the effects of I/R on remote organs (lungs and heart) were harvested for analysis. We evaluated tissue
levels of myeloperoxidase, interleukin-6, and heat shock protein (HSP-70) were analyzed as markers oxidative stress
and inflammation. Histological analyses of the organs were performed.
Results: The lungs paranchymal MPO and HSP-70 levels significantly decreased (p<0.05), but IL-6 level was not
significant (p>0.05) in heparinized and high dose heparinized groups when compared to ischemic control group.
Histopathological evaluation as edema, cell degeneration, inflammation statistically significantly decreased in both
group heparinized and high dose heparinized compared with ischemic control group (p<0.05). The heart
paranchymal MPO levels significantly decreased in heparinized and high dose heparinized groups when compared
to ischemic control group (p=0.023). IL-6, HSP-70 levels were not significant heparinized and high dose heparinized
groups when compared to ischemic control group (p=0.0489, p=0.0143). Histopathological evaluation as
degeneration statistically significantly decreased in both group heparinized and High dose heparinized compared
with ischemic control group (p=0.005).
Conclusion: Heparin decreased remote organs injury on the lung and heart after ischemia/reperfusion of infra-renal
section of the body in the rat model. So, we should be balance to act level for avoid to I/R injury per operative and
early post operative period as providing ACT level nearly 200.* Correspondence: drselcukg@hotmail.com
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Thoraco-abdominal aortic surgery can cause Ischemia/
Reperfusion I/R injury in not only the spinal cord, but
also in the remote organs such as lungs and heart during
the operations [1].
It can result in mortality and morbidity because of
remote organ injury in early post-operative period.
Despite the exact pathophysiologic mechanism that
underlie ischemia reperfusion of the lower body sustain
to be defined inflammatory response is known to play an
important role after ischemia subscribes to remote organ
injury [2,3].
Cytokines such as IL-6 are important mediators of the
inflammatory response in ischemia. IL-6 is released in
response to infection, burns, trauma and neoplasia and
its functions range from key roles in acute phase protein
induction to B and T cell growth and differentiation [4].
The cellular stress response can mediate cellular protec-
tion trough expression of heat shock protein (HSP-70),
which can interfere with the process of apoptotic cell
death [5-7].
Myeloperoxydase (MPO) is one of the distinct indica-
tors for the tissue infiltration of neutrophilic granulo-
cytes. MPO activity which is response to the ischemia
reperfusion injury increases in the end organ tissue sub-
stantially [8].
The objective of our study is to prevent thrombus
formation in the microcirculation by monitoring the
effectiveness of heparin, in this way to demonstrate how
much we could suppress inflammation occurring after
ischemia / reperfusion by limiting ischemia.
Method
Animal and surgical procedure
This study was approved by the Animal Experimental
Committee of Duzce University Graduate School of Medi-
cine Animal care and all procedures were performed
according to guide for the care and use the National In-
stitute of Heat’s. Rats weighed between 250 and 350 gr
and a total of 28 male Spraque-Dawley rats were used for
the experiment. The animals were fed a standard rat
chow using the same nutrition protocol and were then
studied. None of them had any neurological disorders
before operation. Hemochron Jr signature plus (Keller
Medical GmbH, Bad Soden, Germany) was used to
detect ACT level.
Study groups
Animals were divided into four groups. Sham group
(n=7) was appointed as Group-1. The operation was per-
formed in the same way, but without aortic occlusion
and heparin administration. Only laparatomy was per-
formed in this group. Non- heparinized control group
(n=7) was appointed as Group 2. In this group animals’abdominal aortas were clamped for 45 minutes by an
aneurysm clip, approximately 1cm below renal arteries
and 1cm above the iliac bifurcation. Heparin treated
group (n=7) was appointed as Group 3. 400 IU/kg of
heparin was administered via intraperitoneal to all animals
immediately before the procedure. High dose heparin
treated group (n=7) was appointed as Group-4. In this
group heparin dose was increased 800 IU/kg for ACT level
of 600 sec immediately before the procedure. All cross-
clamped groups were reperfused after spinal cord ischemia.
Operative procedure and technique
Rats were premedicated with ketamine (50 mg/kg) and
xylazine (5 mg/kg) intraperitoneally. The maintenance
of anesthesia was established with intermittent deliv-
ery of ketamine, without endotracheal intubation and
mechanical ventilation. Intraperitoneal cephalosporine
(10 mg/kg) was administered before skin incision. Post-
operative analgesia was provided with tramadol per 12
hours. Temperature probe was inserted into the rectum.
After the surface cleaning of the surgical area and
standard midline laparatomy, the abdominal aorta was
explored trough a transperitoneal approach retracting
the intestines. The abdominal aorta was clamped with
mini aneurysm clamp between below renal arteries above
the iliac bifurcation. Temperature was maintained be-
tween 36,5 and 37,5°C during the spinal procedure with
heating lamp. Artery blood pressure and heartbeat were
monitored continuously the left carotid artery cannula.
After administrating study protocol in all rats, aortic
clamps were removed and anterior abdominal wall was
sutured by using 5/0 polyprolene suture.
At 48th hour the all animals were anesthetized with
penthobarbital (20 mmg/kg) and sacrificed. The lungs
and heart were dissected totally and fixed in buffered
formalin for 7 days.
Experiment-1: inflammatory markers production
In this experiment the production of the inflammatory
markers IL-6, HSP-70, MPO were studied in four groups
of animals. Blood samples were obtained at the end of
48 h. At the time of blood sampling the chest wall was
cleansed with cholorohexidine in spirit, and a sterile
10ml syringe was then used to obtain a blood sample by
direct cardiac puncture. Blood samples for cytokine
assay were collected into heparinized (20 unit/ml blood)
sterile tubes and immediately transferred on ice to be
centrifuged at 2000 rpm (at 4°C) for 10 minutes and
stored (−70°C) until the time of assay for IL-6, MPO and
HSP-70.These markers level obtained not only from
blood samples but also from lungs and heart tissue.
Experiment-2: Histopahological Assessment
A midline laparotomy was performed to all animals
immediately following blood sampling and total lobe of
Table 1 Histopathologic results of the lung tissue
H&E Grade Ischemic control Sham Heparinized High dose-heparinized P values
Number % Number % Number % Number %
Edema 0 0 0 3 42.9 4 57.1 4 57.1 0.032
1 7 71.4 4 57.1 3 42.9 3 42.9
Inflammation 1 4 57.1 7 100 6 85.7 7 100 0.012
2 3 42.9 0 0 1 14.3 0 0
Cell Degeneration 0 0 0 0 0 0 0 1 14.3 <0.0001
1 0 0 7 100 6 85.7 6 85.7
2 6 85.7 0 0 1 14.3 0 0
3 1 14.3 0 0 0 0 0 0
Congestion 0 0 0 1 14.3 0 0 0 0 0.124
1 3 42.9 6 85.7 6 85.7 7 100
2 3 42.9 0 0 1 14.3 0 0
3 1 14.3 0 0 0 0 0 0
Figure 1 H & E x100 staining of the lung tissue. Left abobe;
control group with intense cellular degeneration, edema,
inflammation and congestion. Left-below: High dose heparin group
was similar with the sham group (right below). The injury was
moderate in the heparin group (right above).
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malin for histopathologic examination. Paraffin sections
(4 μm thickness) were prepared. The slides were evaluated
under light microscopy (Olympus BX51; Olympus Corp.,
Tokyo, Japan) at 400x magnification. 5 μm thick sections
were placed on polylysine-coated slides and stained with
hematoxylin and eosin (H & E).
Immunohistochemistry
Analysis of HSP Paraffin sections (4 μm thick) were
prepared. Tissue sections were deparaffinized and
hydrated in xylenes and graded alcohol. The sections
were incubated with primary anti-HSP70 (clone BRM.22,
dilution 1/80, Biogenex, San Ramon, California) diluted
in buffer. PBS was used as negative control.
Analysis of IL-6
The polyclonal anti-human IL-6 receptor antibody C-20
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA) was
used for the immunohistochemical detection of IL-6
receptor. This antibody was diluted 1: 20. IL-6 receptor
immunostaining was also performed according to a
streptavidin-biotin-peroxidase protocol. The secondary
anti-rabbit antibody was diluted 1: 500. Negative controls
were performed by omitting the first antibody.
Analysis of MPO
The lung and heart tissue MPO activities were evaluated
immuno-histochemically using an anti-MPO kit accord-
ing to the manufacturer’s protocol. Briefly, samples on
polylysine-coated slides were deparaffinized and rehy-
drated. Then, the microwave antigen retrieval procedure
was performed, and the samples were incubated in a
3% H2O2 solution to inhibit endogenous peroxidase. Toblock nonspecific background staining, the sections were
incubated with a blocking solution. Then the sections
were incubated with primary anti-MPO antibody, followed
by incubation with biotinylated goat anti-mouse antibody.
After incubating with the chromogenic substrate (DAB),
the sections were counterstained with hematoxylin and
eosin (H & E).
The slides were examined under a light microscope and
all analyses were performed by two pathologists blinded to
the group assignments. The staining of cytoplasmic MPO
in the neutrophils was evaluated, and the results were
expressed as the percentage of neutrophils cytoplasmi-
cally stained positive for MPO.
Tissues with no evidence of staining, or only rare
scattered positive cells, less than 3%, were recorded
Figure 2 Left panel: MPO staining was intense in the control
group. Right panel: Less intense staining in the high dose heparin
group (MPOX200).
Figure 3 Staining with HSP-70 was stronger in the control
group (Right panel) than the high dose heparin group
(HSP-70X200).
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ated for intensity and frequency of staining. The intensity
of staining was graded as 0 (negative), 1 (weak), 2
(moderate), and 3 (strong). The frequency was graded
from 0 to 4 by the percentage of positive cells as follows:
grade 0, <3 %; grade 1, 3-25%; grade 2, 25-50%; grade 3,
50-75%; grade 4, more than 75%. The index score was
the product of multiplication of the intensity and fre-
quency grades, which was then classified into a 4 point
scale: index score 0 = product of 0, index score 1 =
products 1 and 2, index score 2 = products 3 and 4,
index score 3 = products 6 through 12.
Statistical analysis
Statistical analysis and calculations were performed
by using SPSS 15 for Windows (Chicago,IL). Results
were expressed as the mean (standard error mean).
Kruskal-Wallis analysis of variance was used to de-
tect differences between groups and statistical com-
parisons were made using the Mann–Whitney U test.Table 2 Immunohistochemical results of the lung tissue
Grade Ischemic control Sham
Number % Number %
MPO 0 0 0 4 57.1
1 5 71.4 3 42.9
2 2 28.6 0 0
HSP 0 0 0 4 57.1
1 5 71.4 3 42.9
2 2 28.6 0 0
IL-6 0 0 0 4 57.1
1 6 85.7 3 42.9
2 1 14.3 0 0A p value of < .01 was considered statistically signifi-
cant. A p value of < .05 was considered statistically
less significant.
Results
There was no significant difference in terms of body
temperature and arterial blood pressure.
Histopathological and immunohistochemical evaluation
The lung tissue was evaluated. Ischemic control
group of the examination compared with sham group
showed more edema, inflammation and cell degener-
ation according to histopathologic evaluation. Edema,
inflammation and cellular degeneration differed sig-
nificantly between the study groups (p value 0.032,
0.012 and < 0.0001, respectively). However level of
congestion was similar (p=0.124) Therefore there was
significantly more edema, inflammation and cellular
degeneration in the ischemic control group (Table 1
and Figure 1).heparinized High dose heparinized P value
Number % Number %
2 28.6 5 71.4 0.019
5 71.4 2 28.6
0 0 0 0
2 28.6 2 28.6 0.050
5 71.4 5 71.4
0 0 0 0
2 28.6 4 57.1 0.089
5 71.4 3 42.9
0 0 0 0
Figure 4 IL-6 staining (left panel) and mild staining with
HSP-70(right panel) in the high dose heparin group (X200).
Figure 5 Mild degeneration, congestion and several
inflammatory cells in the heart tissue of the control group
(left panel). Moderate staining with MPO (right panel) (X200).
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IL-6 parameters were studied from the lung tissue sam-
ples. Statistical difference was found among the groups
at 48 hours postoperatively with MPO and hsp-70 stains
(p value 0.019 and 0.05, respectively), whereas there was
no difference among the groups with IL-6 stain
(p=0.089) (Figure 2). Significant difference was seen in
the Sham group when compared with the other groups.
Intensity of staining with MPO was greatest in the ische-
mic control group followed by heparin group. Also, con-
trol group showed the most intense staining with Hsp-70
(Table 2) (Figure 3). The lowest HSP-70 level was mea-
sured in the sham group, after heparinized groups while
the highest HSP-70 level was measured in the ischemic
control group.
Examination of the heart tissue revealed that ischemic
control group showed more degeneration according to
histopathologic evaluation (p=0.005); whereas there was
no difference between the groups according to the level
of edema, inflammation and congestion (p values, 0.613,
0.499 and 0.558, respectively (Figure 4). DegenerationTable 3 Histopathological results of the heart tissue
Grade High dose-heparinized Sham
Number % Number
Edema 0 4 57.1 5
1 3 42.9 2
Inflammation 0 3 42.9 5
1 4 57.1 2
Degeneration 0 4 57.1 6
1 3 42.9 1
2 0 0 0
Congession 0 4 57.1 5
1 3 42.9 2was worst in the ischemic control group followed by hep-
arin and high dose-heparin groups (Table 3).
Comparison of immunohistochemical markers of the
heart tissue revealed that there was a significant differ-
ence with MPO staining (p=0.023) which was strongest
in the control group, where as IL-6 and Hsp-70 levels
did not differ among the groups (p values, 0.483 and
0.4 respectively) (Figure 5).
Grade 1 and 2 staining with HSP-70 was strongest in
the control group (n=4 and n=1, respectively) where as it
was weakest in the high dose heparinized group. Grade 1
staining was strongest with IL-6 in the control group
(n=6) where as it was again weakest in the high dose
heparinized group (Figure 6) These qualitative differ-
ences did not reach statistical significance possibly due to
the low number of samples (Table 4).
Discussion
Thoracoabdominal aortic surgery can cause systemic
inflammatory response and ischemia occurs when theİschemic control Heparinized P value
% Number % Number %
71.4 5 71.49 5 71.4 0.613
28.6 2 28.6 2 28.6
71.4 3 42.9 5 71.4 0.499
28.6 4 57.1 2 28.6
85.7 0 0 1 14.3 0.005
14.3 6 85.7 6 85.7
0 1 14.3 0 0
71.4 6 85.7 6 85.7 0.558
28.6 1 14.3 1 14.3
Figure 6 Moderate staining with IL-6 (left panel) and HSP-70
(right panel) in the heart tissue of the control group (X200).
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blood to remote organs slowed or stopped [9,10]. So,
microthrombus formation associated with blood flow
slowing or stopping causes widespread inflammation and
severe ischemia. This process causes of multiorgan dis-
orders and associates with histopathological and func-
tional changes [11,12]. Thoracoabdominal aortic clamping
can cause transient ischemia may be an inevitable conse-
quence of descending or thoracoabdominal aortic surgery
due to microthrombus formation for inadequate heparin
dose. Especially, when the hematocrit level is higher than
40 mg/dl microthrombus may easily form. It was sug-
gested that microcirculatory disturbances such as higher
blood viscosity due to hemoconcentration and micro-
thrombus formation were related to the ischemia [13].
Heparin has beneficial effects on organs injury in the
events due to its anticoagulant activity [14].
The present study showed that levels of HSP-70, IL-6
and MPO at the tissue level after ischemia/reperfusion
were increased. Intensity of edema, cellular degeneration
and congestion in the lung tissue after I/R was decreased
after heparin treatment and the histopathologic protect-
ive effect of heparin was shown in the present study.Table 4 Immunohistochemical results of the heart tissue
Grade Ischemic control Sham
Number % Number %
MPO 0 0 0 4 57.1
1 7 100 3 42.9
HSP 0 2 28.6 5 71.4
1 4 57.1 2 28.6
2 1 14.3 0 0
IL-6 0 1 14.3 4 57.1
1 6 85.7 3 42.9Myeloperoksidaz and IL-6 are acute phase proteins and
increases with inflammation [15,16]. HSP-70 is a well
known cytoprotective agent and increases after I/R and its
level is directly related with the degree of tissue injury and
inflammation. In the present study, HSP-70 level was
highest in the control group, followed by heparin, high
dose- heparin and sham groups.
Heat shock protein 70 (Hsp70) has been shown to
have an anti-apoptotic function, but its mechanism is
not clear in heart. Histopathologic changes were mild in
heart. Only cellular degeneration showed significant dif-
ference among groups after I/R [17,18]. The changes in
IL-6 and HSP-70 should be studied in larger cohorts.
Lower levels of MPO in heart and lung tissue after I/R
in the heparin ve high dose heparin groups, showed that
the inflammation and injury was significantly lower with
this treatment. The decrease in HSP-70 in these groups
also was an indirect proof of lower tissue injury and
better cellular protection. Markers of injury and repair
were analyzed together in the present study.
The half-life of heparin increases from approximately
30 min following an IV bolus of 25 U/kg, to 60 min with
a bolus of 100 U/kg, and to 150 min with a bolus of
400 U/kg [19]. We administer heparin dose 100 u/kg
bolus and maintain ACT level as 200 in abdominal aortic
surgery, routinely. In the present study there was no signifi-
cant difference between heparin groups (ACT: 200 and
ACT: 600) in terms of histopathologic changes or bio-
chemical inflammatory response in the lungs and heart.
Also, clinical pattern was not different between the
groups. The HSP-70 expression was significantly higher
and MPO activity was significantly lower in ischemic
control group compared with heparin groups.
Conclusion
ACT levels of 200, as used in the real-world clinical prac-
tice, should be maintained in the open heart surgery. No
beneficial effects were seen with the use of higher levels of
ACT in the present study. Taking into account that, bleed-
ing complications will be much less the target dose of hep-
arin should be maintained at this level in daily practice.Heparinized High dose-heparinized P value
Number % Number %
4 57.1 4 57.1 0.023
3 42.9 3 42.9
4 57.1 5 71.4 0.489
3 42.9 2 28.6
0 0 0 0
3 42.9 5 71.4 0.143
4 57.1 2 28.6
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